NetworkNewsBreaks

FridayDec 18, 2020 10:41 am

NetworkNewsBreaks – Roku Inc. (NASDAQ: ROKU) Featured in Analysis Report

Roku Inc. (NASDAQ: ROKU), a manufacturer of various digital media players for video streaming, was featured in a recent analysis report that discussed its standout performance this year. The report, written by LikeFolio Founder Andy Swan, reads, “ROKU has been a runaway winner in 2020 and, thanks to an upgrade from Citigroup, the stock is trading at a new all-time high today. Although the company’s total PI volume, which includes device purchases, is showing a -9% YoY decline in the current quarter, the number of consumers talking about watching and streaming content on a Roku device is still trending higher:…

Continue Reading

FridayDec 18, 2020 10:24 am

NetworkNewsBreaks – Pixelworks Inc. (NASDAQ: PXLW) Secures $13.8M in Underwritten Public Offering

Pixelworks (NASDAQ: PXLW) has closed an underwritten public offering of 5,635,000 shares of its common stock, including 735,000 additional shares per the full exercise of the over-allotment option granted to the underwriters. According to the update, Pixelworks secured approximately $13.8 million in gross proceeds, with each of the shares sold at a public offering price of $2.45. Roth Capital Partners (“ROTH”) acted as joint book-running manager for the offering. To view the full press release, visit https://nnw.fm/I7gJu About Pixelworks Inc. Pixelworks provides industry-leading content creation, video delivery and display processing solutions and technology that enable highly authentic viewing experiences with…

Continue Reading

FridayDec 18, 2020 9:45 am

NetworkNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Commencement, Pricing of Underwritten Public Offering

VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, has announced the commencement and pricing of an underwritten public offering. The offering consists of 63,000,000 shares of its common stock at an offering price of $0.92 per share, par value $0.001 per share (the “Common Stock”), and 2,000,000 shares of its Series D convertible preferred stock (“Series D Preferred Stock”) at a public offering price of $21.16 per share. VistaGen expects $100 million in gross proceeds from the offering, before underwriting discounts, commissions and estimated offering expenses. Subject to…

Continue Reading

FridayDec 18, 2020 9:13 am

NetworkNewsBreaks – Chewy Inc. (NYSE: CHWY) Featured in Analysis Report

Chewy (NYSE: CHWY), a leading online source for pet products, supplies and prescriptions, was featured in a recent analysis report that discussed its surging performance during the pandemic. The report, written by LikeFolio Founder Andy Swan, reads, “Chewy was one of our favorite COVID plays. We featured the name on our Coronavirus Shopping List MegaTrends Report, delivered to clients at the end of March . . . when shares were around $36. Since then, shares have more than doubled in value.” For more information, visit www.Investor.Chewy.com About Chewy Inc. Chewy’s mission is to be the most trusted and convenient online…

Continue Reading

FridayDec 18, 2020 8:30 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Hosts Conference Call to Discuss IND Approval, Phase 2 Berubicin Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, on Thursday announced that it will be holding a conference call to discuss its recently approved Investigational New Drug (“IND”) application involving its lead product candidate Berubicin for the treatment of Glioblastoma Multiforme (“GBM”). The company also intends to discuss its planned Phase 2 Berubicin clinical trial on the call slated for Friday, December 18, 2020 at 8:30 AM ET. Interested parties may access the call by dialing (800) 226-2188 (domestic) or (602) 563-8462 (international)…

Continue Reading

ThursdayDec 17, 2020 2:52 pm

NetworkNewsBreaks – Sustainable Green Team Ltd. (SGTM) Achieves Key Milestones, Eyes Uplist

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, has achieved several accomplishments as recently published in its financial results for the third quarter of 2020. Among these, the company reported a rise in fiscal revenues to $24.5 million over the first nine months of 2020. A recent article discussing this quotes SGTM’s CEO and Director Tony Raynor in reference to the results. “I am proud of our team and the progress we have made this year in achieving these key milestones,” Raynor said. “We plan to proceed in a similar…

Continue Reading

ThursdayDec 17, 2020 2:39 pm

NetworkNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) Holds Key Elements Critical for Today’s Mining

GoldHaven Resources (CSE: GOH) (OTCQB: GHVNF), a Canadian junior exploration company, leverages key strengths that are essential in the current mining sector. David Elliott, a new member of the premier Canadian Mining Hall of Fame, called out distinctive factors for successful companies during an interview at the recent Global Mining Symposium. He noted that the right people and the right science are critical elements investors consider when determining which mining companies are optimal for investment (https://nnw.fm/gBnSR). GoldHaven is well equipped with strengths investors seek when making decisions about capital placement. An article discussing this reads, “As a Canadian junior mining company…

Continue Reading

ThursdayDec 17, 2020 2:05 pm

NetworkNewsBreaks – Loop Insights Inc. (TSXV: MTRX) (OTCQB: RACMF) Enters Strategic Partnership, Eyes ‘Global Opportunities Never Thought Possible’

Loop Insights (TSXV: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick-and-mortar space, today announced its entry into a global partnership agreement with NTT DATA Corp of Japan (TYO: 9613). NTT DATA is a global leader in technology services and a top-ranked global Internet of Things (“IoT”) consulting and system integration services company, with US$20 billion in revenues in 2020. Under the agreement, Loop and NTT DATA intend to combine their respective strengths to create new recurring revenue models for both companies. “Our…

Continue Reading

ThursdayDec 17, 2020 12:20 pm

NetworkNewsBreaks – Brain Scientific Inc. (BRSF) Announces NeuroCap for Children, Enters Pediatric Market

Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has launched its next-generation, disposable EEG cap, NeuroCap(TM) in a children’s size, making the innovative product available for use in the U.S. pediatric market. The smaller NeuroCap headset is designed to overcome common challenges that arise when conducting an electroencephalogram (“EEG”), such as measuring and marking the patient’s head, and following sanitation protocols. The pediatric NeuroCap also addresses the need for comfort, speed and reliability within the pediatric population. BRSF’s disposable, pre-gelled NeuroCap features 19 active EEG channels and 22 electrodes and can be quickly, easily and accurately applied by any…

Continue Reading

ThursdayDec 17, 2020 11:41 am

NetworkNewsBreaks – Delcath Systems Inc. (NASDAQ: DCTH) Secures $22.2M in Underwritten Public Offering

Delcath Systems (NASDAQ: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, has closed an underwritten public offering of 1,679,031 shares of its common stock, including 219,004 additional shares per the full exercise of the over-allotment option granted to the underwriters. According to the update, Delcath Systems secured approximately $22.2 million in gross proceeds with each of the shares sold at the public offering price of $13.25. The company intends to use the net proceeds for completion of its FOCUS clinical trial for patients with hepatic dominant ocular melanoma, preparation of…

Continue Reading